UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 9 | September 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 12 Issue 9
September-2025
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2509432


Registration ID:
569590

Page Number

e297-e306

Share This Article


Jetir RMS

Title

REVERSE PHASE HIGH PRESSURE LIQUID CHROMATOGRAPHIC METHOD DEVELOPMENT AND VALIDATION OF DAPAGLIFLOZIN IN BULK AND SOLID DOSAGE FORM

Abstract

A simple, accurate, sensitive RP-HPLC method was developed for the determination of Dapagliflozin in bulk and it’sfilm coated tablet dosage form. The chromatographic separation was achieved on a reverse phase C18 Peerless Basic Column (250 mm×4.6 mm×5 μm). The mobile phase system consisting of acetonitrile and water (90:10v/v), was pumped using isocratic mode at 1mL/min flow rate. Detection of drug was made spectrophotometrically at a wavelength 223 nm using PDA detector and column temperature was adjusted at 30℃. The retention time was found to be 3.30 min. The method was validated to fulfil International Council on Harmonization (ICH) requirements and included specificity, linearity, precision, accuracy, limit of detection (LOD), limit of quantification (LOQ), robustness. The analyte response was instituted to be linear from range 10-60 μg/ml with a regression value of 0.997. % recovery was obtained as 100.59%, 100.45%, 101.29%. Limit of Detection and Limit of Quantification was found to be 2.91 μg/ml and 8.92 μg/ml. The method was found statistically accurate, precise with relative standard deviation (%RSD) values <2.0% and robust. Thus, proposed method is convenient, efficient and useful in routine analysis for estimation of Dapagliflozin in its bulk form and film coated tablet dosage form. Index Terms: Dapagliflozin, Method Development and Validation, RP-HPLC.

Key Words

Cite This Article

"REVERSE PHASE HIGH PRESSURE LIQUID CHROMATOGRAPHIC METHOD DEVELOPMENT AND VALIDATION OF DAPAGLIFLOZIN IN BULK AND SOLID DOSAGE FORM", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 9, page no.e297-e306, September-2025, Available :http://www.jetir.org/papers/JETIR2509432.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"REVERSE PHASE HIGH PRESSURE LIQUID CHROMATOGRAPHIC METHOD DEVELOPMENT AND VALIDATION OF DAPAGLIFLOZIN IN BULK AND SOLID DOSAGE FORM", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 9, page no. ppe297-e306, September-2025, Available at : http://www.jetir.org/papers/JETIR2509432.pdf

Publication Details

Published Paper ID: JETIR2509432
Registration ID: 569590
Published In: Volume 12 | Issue 9 | Year September-2025
DOI (Digital Object Identifier):
Page No: e297-e306
Country: thane, maharashtra, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00028

Print This Page

Current Call For Paper

Jetir RMS